DK1194575T4 - Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling heraf - Google Patents

Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling heraf

Info

Publication number
DK1194575T4
DK1194575T4 DK00942494T DK00942494T DK1194575T4 DK 1194575 T4 DK1194575 T4 DK 1194575T4 DK 00942494 T DK00942494 T DK 00942494T DK 00942494 T DK00942494 T DK 00942494T DK 1194575 T4 DK1194575 T4 DK 1194575T4
Authority
DK
Denmark
Prior art keywords
csf
stimulating factor
colony stimulating
modified
human granulocyte
Prior art date
Application number
DK00942494T
Other languages
Danish (da)
English (en)
Other versions
DK1194575T3 (da
Inventor
Se Chang Kwon
Sung Youb Jung
Sung Min Bae
Gwan Sun Lee
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36129291&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1194575(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Application granted granted Critical
Publication of DK1194575T3 publication Critical patent/DK1194575T3/da
Publication of DK1194575T4 publication Critical patent/DK1194575T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00942494T 1999-07-08 2000-07-07 Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling heraf DK1194575T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019990027418A KR100356140B1 (ko) 1999-07-08 1999-07-08 인간 과립구 콜로니 자극인자 변이체 및 이의 생산 방법
PCT/KR2000/000733 WO2001004329A1 (en) 1999-07-08 2000-07-07 Modified human granulocyte-colony stimulating factor and process for producing same

Publications (2)

Publication Number Publication Date
DK1194575T3 DK1194575T3 (da) 2005-10-17
DK1194575T4 true DK1194575T4 (da) 2009-12-07

Family

ID=36129291

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00942494T DK1194575T4 (da) 1999-07-08 2000-07-07 Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling heraf

Country Status (16)

Country Link
US (2) US20040224393A1 (https=)
EP (1) EP1194575B2 (https=)
JP (1) JP2003504069A (https=)
KR (1) KR100356140B1 (https=)
CN (1) CN1195859C (https=)
AT (1) ATE299187T1 (https=)
AU (1) AU757147C (https=)
BR (2) BRPI0012265B8 (https=)
CA (1) CA2378543C (https=)
DE (1) DE60021188T3 (https=)
DK (1) DK1194575T4 (https=)
ES (1) ES2243275T5 (https=)
NZ (1) NZ516476A (https=)
PT (1) PT1194575E (https=)
RU (1) RU2232772C2 (https=)
WO (1) WO2001004329A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6831158B2 (en) 2000-01-10 2004-12-14 Maxygen Holdings Ltd. G-CSF conjugates
EP1425304B9 (en) 2001-07-11 2010-09-08 Maxygen, Inc. G-csf conjugates
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
US20090226397A1 (en) 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
EP2196210A1 (en) 2003-10-24 2010-06-16 Nora, LLC A method for reducing the likelihood of preeclampsia in a subject in need thereof
US8338373B2 (en) * 2003-10-24 2012-12-25 Nora Therapeutics, Inc. Method for reducing the risk of spontaneous abortion in a human female subject
KR20080027291A (ko) 2005-06-01 2008-03-26 맥시겐 홀딩스 엘티디 피이지화된 지-씨에스에프 폴리펩타이드 및 그 제조방법
DE102005033250A1 (de) 2005-07-15 2007-01-18 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von G-CSF
EP2274325A4 (en) * 2008-05-13 2011-05-25 Nora Therapeutics Inc ANALOGUE OF HUMAN G-CSF AND METHOD OF MANUFACTURE AND APPLICATION THEREOF
PT2525787T (pt) 2010-01-19 2017-12-18 Hanmi Science Co Ltd Formulações líquidas para conjugado de g-csf de longa ação
RU2612884C2 (ru) 2010-04-02 2017-03-13 Курна, Инк. Лечение заболеваний, связанных с колониестимулирующим фактором 3 (csf3), путем ингибирования природного антисмыслового транскрипта k csf3
KR101831300B1 (ko) * 2010-10-29 2018-02-23 한미사이언스 주식회사 재조합 대장균으로부터 인간 과립구 콜로니 자극인자를 정제하는 방법
RU2467764C2 (ru) * 2011-01-12 2012-11-27 Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Пензенский институт усовершенствования врачей" Министерства здравоохранения и социального развития Российской Федерации Способ лечения больных аутоиммунной хронической крапивницей с использованием внутривенного введения препарата "габриглобин"
WO2016013725A1 (ko) * 2014-07-23 2016-01-28 주식회사 이큐스앤자루 과립구 콜로니 자극인자 변이 단백질 또는 이의 트랜스페린 융합 단백질을 유효성분으로 포함하는 약학적 조성물
KR101623906B1 (ko) 2014-07-23 2016-05-24 주식회사 이큐스앤자루 과립구 콜로니 자극인자 변이 단백질 또는 이의 트랜스페린 융합 단백질을 유효성분으로 포함하는 약학적 조성물
CN110545849A (zh) 2017-02-03 2019-12-06 韩美药品株式会社 具有增加的持续性的生理活性物质的缀合物及其应用
US11267858B2 (en) 2019-05-31 2022-03-08 Spectrum Pharmaceuticals, Inc. Methods of treatment using G-CSF protein complex
US11684655B2 (en) 2019-05-31 2023-06-27 Spectrum Pharmaceuticals, Inc. Methods of treating neutorpenia using G-CSF protein complex
KR102375269B1 (ko) * 2021-01-27 2022-03-17 한미약품 주식회사 단백질 액상 제제 및 이의 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810643A (en) * 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
AU7675487A (en) * 1986-08-11 1988-05-19 Cetus Corporation Expression of granulocyte colony-stimulating factor
US5362853A (en) * 1986-12-23 1994-11-08 Kyowa Hakko Kogyo Co., Ltd. Polypeptide derivatives of human granulocyte colony stimulating factor
US5681720A (en) * 1986-12-23 1997-10-28 Kyowa Hakko Co., Ltd. DNA encoding human granulocyte colony stimulating factor plasmids and host cells comprising same, and methods of expressing the encoded polypeptide
JPH02104598A (ja) 1988-04-12 1990-04-17 Kirin Amgen Inc ヒト顆粒球コロニー刺激因子ポリペプチド誘導体
NZ236819A (en) * 1990-02-03 1993-07-27 Max Planck Gesellschaft Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions
GB9107846D0 (en) * 1990-04-30 1991-05-29 Ici Plc Polypeptides
EP0626448A3 (de) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
US6476198B1 (en) * 1993-07-13 2002-11-05 The Scripps Research Institute Multispecific and multivalent antigen-binding polypeptide molecules
US5451660A (en) * 1993-12-13 1995-09-19 Genentech, Inc. Method for purifying polypeptides
JPH09511916A (ja) * 1994-11-01 1997-12-02 ベルス，ビンフリート 核酸伝達系
US6100070A (en) * 1995-10-05 2000-08-08 G. D. Searle & Co. G-CSF receptor agonists
KR100316347B1 (ko) * 1998-09-15 2002-08-27 한미약품(주) 대장균엔테로톡신ⅱ신호펩티드의변형체와인체성장호르몬의융합단백질을발현하는재조합미생물및그를이용한인체성장호르몬의제조방법
IL152804A0 (en) * 2000-05-16 2003-06-24 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues

Also Published As

Publication number Publication date
RU2232772C2 (ru) 2004-07-20
KR20010009171A (ko) 2001-02-05
EP1194575A1 (en) 2002-04-10
KR100356140B1 (ko) 2002-10-19
ES2243275T5 (es) 2009-12-02
BRPI0012265B8 (pt) 2021-05-25
BRPI0012265B1 (pt) 2018-11-21
US7704709B2 (en) 2010-04-27
AU757147B2 (en) 2003-02-06
EP1194575A4 (en) 2002-10-24
EP1194575B2 (en) 2009-08-26
ES2243275T3 (es) 2005-12-01
CN1195859C (zh) 2005-04-06
DE60021188T3 (de) 2010-04-01
AU757147C (en) 2005-03-03
BR0012265A (pt) 2002-03-12
DE60021188D1 (de) 2005-08-11
CA2378543C (en) 2010-05-18
US20040224393A1 (en) 2004-11-11
DE60021188T2 (de) 2006-04-27
WO2001004329A1 (en) 2001-01-18
NZ516476A (en) 2003-09-26
ATE299187T1 (de) 2005-07-15
JP2003504069A (ja) 2003-02-04
CN1360636A (zh) 2002-07-24
CA2378543A1 (en) 2001-01-18
PT1194575E (pt) 2005-10-31
AU5710600A (en) 2001-01-30
EP1194575B1 (en) 2005-07-06
DK1194575T3 (da) 2005-10-17
US20080064066A1 (en) 2008-03-13

Similar Documents

Publication Publication Date Title
DK1194575T4 (da) Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling heraf
PL331351A1 (en) Novel strains of escherichia coli, methods of obtaining them and their application in l-treonin production fermentation processes
IL145288A (en) Isolated cytokine zalpha11 ligand polypeptide and uses thereof
DK1317537T3 (da) Sammensætninger og fremgangsmåder med G-CSF analoger
NZ595500A (en) Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
DE69929805D1 (de) Modifiziertes e.coli enterotoxin ii signalpeptid sowie ein mikroorganismus der ein fusionsprotein sowie ein heterologes protein exprimiert
DE59104720D1 (de) Antifungisches polypeptid, verfahren zu seiner herstellung.
ATE77104T1 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
DE3683267D1 (de) Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung.
DE60228213D1 (de) Verfahren zur herstellung von l-aminosäuren mit stämmen der familie enterobacteriaceae in den das frur-gen deletiert worden ist
SU1720493A3 (ru) Способ получени штамма SтRертососсUS SaNGUIS, способного секретировать @ -1,3-глюкан-3-глюканогидролазу
DE59610632D1 (de) Varianten des humanen rekombinanten interferon-gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
HRP960078B1 (en) Dna sequence coding for a protein of a. thaliana having a delta-5, 7 sterol, delta- 7 reductase activity, delta-7-red protein, production process, strains of transformed yeasts, uses
NZ334568A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
DE69736389T8 (de) Proteine mit zellulase-aktivitäten und prozess für ihre herstellung
RU2009104610A (ru) Штамм enterococcus faecium lvp1073, продуцент бактериоцина против бактериальных патогенов, бактериоцин e1073 против бактериальных патогенов, штамм lactobacillus plantarum 1 lvp7 - индуктор синтеза бактериоцина e1073, сигнальный пептид сп1073-регулятор синтеза бактериоцина e1073, способ получения бактериоцина e1073
MX9605082A (es) Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
CN110396533B (zh) 具有噬菌体抗性的大肠杆菌菌株、筛选方法、重组工程菌表达重组蛋白的制备方法
Mak et al. Formulation and optimization of two culture media for the production of tumour necrosis factor‐β in Escherichia coli
IL158244A0 (en) Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same
FR2785291B1 (fr) Procede de production in vivo de proteines chimiquement diversifiees par incorporation d'acides amines non conventionnels
DE60033823D1 (de) Rekombinante mikroorganismen
SU1144376A1 (ru) Рекомбинатные плазмиды- @ - @ ,кодирующие синтез лейкоцитарного интерферона типа @ - @ человека, и штаммы @ @ / @ - @ - @ -продуценты лейкоцитарного интерферона типа @ -F человека
JPH07203975A (ja) 抗菌活性ペプチドをコードする遺伝子及び抗菌活性ペプチドの製造方法
CN1030962C (zh) 龋齿预防制剂的制备方法